AREV Life Sciences Welcomes Brian V. Elliott to Board of Directors
VANCOUVER, BC -- April 19, 2022 -- NewsGenie -- AREV Life Sciences Global Corp. has announced the appointment of Brian V. Elliott, B Comm, to its Board of Directors. Elliott brings over 35 years of senior management experience in the pharmaceutical industry and health-related public sectors to the company.
Elliott's extensive background includes serving as International Sales Director with Norton Healthcare Generics and Director of Janssen Pharmaceutica NV. He also served as CEO of Tibotec Virco, Ireland. His work with Axios International Consultants Ltd involved numerous developing country health projects, including negotiating with the pharma industry on HIV/AIDS antiretrovirals for UNAIDS.
Elliott has advised major pharmaceutical companies on global access to medicines, working with Johnson & Johnson Global Public Health Group and others. He has also contributed to United Nations Industrial Development Organization (UNIDO), UNAIDS, and WHO on the security of supply of HIV/AIDS commodities.
AREV Life Sciences Global Corp. also announced the issuance of 150,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.22 for a period of 5 years from the issuance date. These options will vest immediately.
AREV Life Sciences Global Corp. is focused on delivering therapeutic interventions to public health through unique compounds, discovery, innovation, and collaborations. The company drives discovery programs for clinical complexities presented by malnutrition, viral infectious diseases, and the inflammatory response system.
Contact: Mike Withrow, arevlifesciences@gmail.com 778-929-6536. For more information visit www.arevlifesciences.com.